Close Menu

carrier screening

NEW YORK (GenomeWeb) — Startup preconception genetic testing company GenePeeks has officially launched its sperm donor screening service, Matchright, with two partner sperm banks.

Gene by Gene will later this year debut a genetic disease carrier screening service focused on Jewish populations in the US.

Recombine is a relatively new genetic testing company that, for the moment, has a genetic disease carrier detection screening test called CarrierMap as its flagship offering.

NEW YORK (GenomeWeb News) – Genetic testing startup Recombine said yesterday that it has raised $3.3 million in a Series A financing.

NEW YORK (GenomeWeb News) - Good Start Genetics said today that it has signed a coverage agreement with Tufts Health Plan for its GoodStart Select sequencing-based carrier screening test.

This is the second in a series of profiles of centers awarded grants this year under NHGRI's Clinical Sequencing Exploratory Research program.

NEW YORK (GenomeWeb News) – Good Start Genetics today said that it has received a clinical lab permit from the New York State Department of Health, enabling the firm to offer its GoodStart Select carrier screening tests to in vitro fertilization and other reproductive health physicians in the sta

NEW YORK (GenomeWeb News) – Next-generation sequencing-based carrier screening firm Good Start Genetics today announced it has closed a non-dilutive loan facility for up to $28 million from Capital Royalty.

With the approval, Quest can offer the test to physicians in New York as well as in all other US states, as New York is the only state with an independent regulatory review process for lab-developed tests.

It remains to be seen whether a market for PCR-based fragile X population screening will soon develop, since mandating newborn testing may be highly dependent on the development of a difference-making therapeutic; and carrier screening will likely continue to rely on a case-by-case cost-benefit analysis.

Pages

UK Royal Statistical Society is organizing a working group to develop guidelines for assessing COVID-19 tests, the Guardian reports.

The Washington Post reports that the White House chief of staff has asked the US Food and Drug Administration to justify the stricter standards it is seeking for a coronavirus vaccine.

President Donald Trump's "good genes" comment raises eugenics concerns, CNN reports.

In PLOS this week: genetic analysis of tremor condition, analysis of a West and Central African tree used in traditional medicine, and more.